Insights

Innovative Oncology Focus StemSynergy Therapeutics specializes in targeting cancer stem/initiating cells by developing novel therapies that modulate critical pathways such as Wnt, Notch, and Sonic Hedgehog. This positions the company as a potential partner or supplier for biotech firms and pharmaceutical companies seeking advanced cancer treatment solutions.

Patent-Backed Technologies With two awarded patents and one pending patent for breakthrough technologies, StemSynergy offers protected, innovative drug candidates that can appeal to investors or licensing partners looking for proprietary oncology assets.

Recent Development Progress The company is actively progressing molecules for clinical development, indicating ongoing R&D success and readiness for potential collaborations with research institutions or clinical trial organizations looking for novel cancer therapeutics.

Growing Revenue Potential With an estimated revenue between 10 million and 25 million dollars and recent focus on clinical development, StemSynergy presents opportunities for investors or partners interested in early-stage, high-growth biotech companies in the oncology sector.

Strategic Market Positioning Positioned in the competitive biotech landscape alongside companies like Epizyme and Gilead, StemSynergy’s unique focus on cancer stem cells and patented technologies offers a compelling value proposition for partnerships aiming to innovate and capture niche markets in cancer therapy.

StemSynergy Therapeutics, Inc. Tech Stack

StemSynergy Therapeutics, Inc. uses 8 technology products and services including WordPress, oEmbed, cPanel, and more. Explore StemSynergy Therapeutics, Inc.'s tech stack below.

  • WordPress
    Content Management System
  • oEmbed
    Dev Tools
  • cPanel
    Hosting Panels
  • Modernizr
    Javascript Libraries
  • Google Tag Manager
    Tag Management
  • Bootstrap
    UI Frameworks
  • Contact Form 7
    Web Platform Extensions
  • jQuery Validation Plugin
    Web Tools And Plugins

StemSynergy Therapeutics, Inc.'s Email Address Formats

StemSynergy Therapeutics, Inc. uses at least 1 format(s):
StemSynergy Therapeutics, Inc. Email FormatsExamplePercentage
Last@stemsynergy.comDoe@stemsynergy.com
50%
Last@stemsynergy.comDoe@stemsynergy.com
50%

Frequently Asked Questions

Where is StemSynergy Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
StemSynergy Therapeutics, Inc.'s main headquarters is located at 1951 Northwest 7th Avenue Suite 300 Miami, Florida 33136 United States. The company has employees across 2 continents, including North AmericaAfrica.

What is StemSynergy Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact StemSynergy Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is StemSynergy Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
StemSynergy Therapeutics, Inc.'s official website is stemsynergy.com and has social profiles on LinkedIn.

What is StemSynergy Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
StemSynergy Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does StemSynergy Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, StemSynergy Therapeutics, Inc. has approximately 6 employees across 2 continents, including North AmericaAfrica. Key team members include Co-Founder: D. R.Director Of Drug Discovery And Development: D. F.Senior Researcher: S. S.. Explore StemSynergy Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does StemSynergy Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
StemSynergy Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does StemSynergy Therapeutics, Inc. use?

Minus sign iconPlus sign icon
StemSynergy Therapeutics, Inc.'s tech stack includes WordPressoEmbedcPanelModernizrGoogle Tag ManagerBootstrapContact Form 7jQuery Validation Plugin.

What is StemSynergy Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
StemSynergy Therapeutics, Inc.'s email format typically follows the pattern of Last@stemsynergy.com. Find more StemSynergy Therapeutics, Inc. email formats with LeadIQ.

StemSynergy Therapeutics, Inc.

Biotechnology ResearchFlorida, United States2-10 Employees

StemSynergy Therapeutics, Inc. (SSTI) is a biotechnology company focused on discovering drugs that target biomolecules and cellular processes fundamental to cancer. We target the cancer stem/initiating cell (CSC) populations, with the overall aim of eliminating tumor growth. We have two patents awarded and one patent pending for breakthrough technologies in modulating cancer stem cell pathways, such as those driven by Wnt, Notch, and Sonic Hedgehog (Shh) signaling. With a multi-pronged scientific approach and a number of agents targeting these pathways, SSTI is well positioned to address critical unmet needs in cancer treatment.

Section iconCompany Overview

Headquarters
1951 Northwest 7th Avenue Suite 300 Miami, Florida 33136 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $10M$25M

    StemSynergy Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    StemSynergy Therapeutics, Inc.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.